Thermography, Thermology and Male Breast Cancer

Promise, Limits and the Work of Dr. Phil Hoekstra

 By: Lennard M. Goetze, Ed.D

Thermal imaging has attracted renewed interest as medicine searches for comfortable, radiation-free methods of assessing breast health. The terms thermography and thermology are often used interchangeably, but they describe different parts of the process. Understanding that distinction is essential—especially when discussing male breast cancer and the work of Dr. Phil Hoekstra.

 Thermography is the imaging technology. A sensitive infrared camera measures heat emitted from the skin and converts those measurements into a color-coded image called a thermogram. The procedure is non-contact, does not compress the breast and does not expose the patient to ionizing radiation.

MEDICAL THERMOLOGY is the broader clinical discipline. It includes standardized patient preparation, controlled room conditions, image acquisition, recognition of thermal patterns, comparison between corresponding areas of the body, clinical interpretation and reporting. Thermography produces the image; thermology provides the scientific framework through which that image is evaluated.

 Why Breast Health Became Thermography’s Best-Known Application: Breast thermography became prominent because the breast is relatively superficial and accessible to infrared measurement. Increased blood flow, inflammation, vascular changes and altered metabolic activity can produce differences in skin temperature. A thermogram may therefore identify asymmetry or an unusual heat pattern that deserves clinical attention.

 Thermography was historically investigated and promoted as a breast-cancer screening method. However, research produced widely variable results, partly because early equipment, acquisition conditions and interpretive criteria were inconsistent. A systematic review found substantial variation in sensitivity and specificity and concluded that evidence was insufficient to support breast thermography as either a screening or diagnostic test by itself.

 Today, the FDA states that thermography has not been demonstrated to be an effective stand-alone test for breast-cancer screening or early detection. It is cleared only as an adjunctive tool, meaning that it may provide supplementary physiologic information but must not replace mammography or another clinically indicated examination. A suspicious thermal pattern is not proof of cancer, while a normal thermogram cannot rule cancer out. FDA, systematic review

 

Dr. Phil Hoekstra’s Contribution

Dr. Phil Hoekstra has devoted decades to thermal imaging and is widely identified within the thermology community as an experienced interpreter and educator. According to Therma-Scan’s published history, Hoekstra and his father established the organization in 1972. His work has emphasized moving beyond the casual production of colorful heat pictures toward a disciplined process involving standardized imaging, clinical-quality interpretation and comparison of thermal findings over time.

 It would be inaccurate, however, to say that Hoekstra “converted thermography into a diagnostic test for cancer.” No thermologist can diagnose breast cancer from temperature patterns alone. The more defensible description is that Hoekstra helped advance thermography toward medical thermology: a structured adjunctive assessment intended to identify physiologic findings that may justify further evaluation. Cancer diagnosis still requires conventional clinical investigation and, ultimately, tissue pathology when warranted. Calling anyone the world’s “leading diagnostic expert” would require independent comparative evidence. Hoekstra can responsibly be described as a longstanding authority and highly experienced specialist in medical thermology, but the limits of the technology must remain clear.

 

What Thermology May Offer Men: Male breast cancer is frequently diagnosed after a man notices a lump, nipple retraction, discharge, skin alteration or another physical change. Because routine population screening is generally not recommended for average-risk men, awareness and prompt evaluation of symptoms are especially important.

Thermology offers practical advantages: it is non-invasive, radiation-free, compression-free and capable of documenting surface-temperature patterns. It may be useful as an adjunct for recording physiologic asymmetry and directing attention to a region requiring conventional examination. These qualities also may make some men more willing to participate in an initial breast-health assessment.

Nevertheless, the claim that mammography “fails men” is not supported by current evidence. Mammography can be highly accurate in symptomatic men; one study reported 92% sensitivity, 90% specificity and a 99% negative predictive value. Ultrasound is also valuable for characterizing a palpable abnormality. The American College of Radiology recommends diagnostic mammography or digital breast tomosynthesis for many men aged 25 or older with an indeterminate breast mass, followed by ultrasound when findings are suspicious or inconclusive. Male mammography study, ACR criteria

 Thermology’s most responsible future is therefore not as a replacement for mammography, ultrasound, MRI or biopsy, but as one component of an integrated diagnostic pathway. For men, the best “new solution” is not reliance on one technology. It is greater awareness, rapid clinical evaluation and thoughtful use of complementary physiologic and structural information—followed by biopsy whenever cancer must be confirmed.